@misc{indiciae1c8b141f4b8c,
  title = {LRR protein RNH1 inhibits inflammasome activation through proteasome-mediated degradation of Caspase-1 and is associated with adverse clinical outcomes in COVID-19 patients.},
  author = {Bombaci, G. and Sarangdhar, M. A. and Andina, N. and Tardivel, A. and Yu, E. C.-W. and Mackie, G. M. and Pugh, M. and Ozan, V. B. and Banz, Y. and Spinetti, T. and Hirzel, C. and Youd, E. and Schefold, J. C. and Taylor, G. S. and Gazdhar, A. and Bonadies, N. and Angelillo-Scherrer, A. and Schneider, P. S. and Maslowski, K. M. and Allam, R.},
  year = {2021},
  doi = {10.1101/2021.04.12.438219},
  url = {https://www.biorxiv.org/content/10.1101/2021.04.12.438219v1},
  note = {Source identifier: 10.1101/2021.04.12.438219}
}